European Biotechnological and Pharmaceutical Patenting in 2015 New Laws & Amendments, Competition, and Litigation
Overview:
The Unified Patent Court is the focus of most intellectual property (IP) and pharmaceutical experts. Regulation and their enforcement of laws against companies for anti-competitive behaviour continue to grow stronger in Europe and America. European Union national courts increasingly refer cases to the European Court of Justice for clarifications and answers to complex issues. Emerging markets keep modifying their IP laws, policies, and procedures which obligate biotechnology and pharmaceutical companies to revise their patent filing, management, and litigation strategies.In this webinar, experts will provide practical advice and solutions to the current challenges facing biotechnology and pharmaceutical companies and help their intellectual property and legal practitioners keep abreast of the latest relevant regulatory changes, legislative initiatives, and case law in the European Union (EU) and the United Kingdom (UK)
During this live webcast, the focus will be upon regulatory updates in the EU and UK regarding pharmaceutical and biotechnological patent law. Experts in patent law will help you understand your legal rights, avoid the stiff anti-competitive sanctions imposed by the EC Commission and the US Federal Trade Commission for ‘pay for delay’ settlements under competition law; provide advice about commercially valuable Supplementary Protection Certificates, and discuss the complexities of competition law, patent filing and litigation strategies, trans-national infringement, managing expiry of patents at home and abroad, and address Bolar and experimental use and research exceptions.
The discussion will include the following key issues:
- Recent Changes in European Patent Case Law and UK Patents Act Amendments
- Claims of UK and European Patent Office and Decisions of the Court of Justice of the European Union
- Interim and Trans-national Infringement and Enforcing of Patents in Developing Countries (India)
- Competition Protection: Laws, Pay-for-delay’, License Refusal, and Reverse
- Patent Expiry: Management, Warnings, Response, and Litigation
- Patent Litigation: Risks, Preparation, Opt-Outs
- Second Medical Use & Dosing Regimen Risks, Protection, Bolar and Research Exemptions in EU, and Supplementary Protection Certificates
Agenda:
Mewburn Ellis LLP
- To opt-out or not to opt-out of the Unified Patents Court – that is the question.
- A new “safer” harbor for clinical trials in the UK?
- New guidance on “Intermediate Generalization” amendments at the EPO and the implications for pharmaceutical applications.
- Guidance from the UK court regarding functional claim language and pharmaceutical patent term extension (Supplementary Protection Certificates).
Carpmaels & Ransford LLP
- Recent Changes in European Patent Case Law and UK Patents Act Amendments
- Claims of UK and European Patent Office and Decisions of the Court of Justice of the European Union
- Second Medical Use & Dosing Regimen Risks, Protection, Bolar and Research Exemptions in EU
Who Should Attend:
- Pharmaceutical and Biotechnological CEOs, CFOs
- Patent Attorneys and In-house Counsel or Legal Advisors
- IP Directors, Intellectual Property Managers, Chief IP Counsel
- Patent Advisors
- Scientific Researchers
- Examiners
- Academics
Joe has a degree and Ph.D. in Chemistry from the University of Durham, UK. His PhD project focussed on catalyst …
Glyn has a patent practice that spans a wide range of biotechnology subject-matter. The majority of his work involves the drafting and …
Course Level:
Intermediate
Advance Preparation:
Print and review course materials
Method of Presentation:
On-demand Webcast (CLE)
Prerequisite:
NONE
Course Code:
144728
NASBA Field of Study:
Specialized Knowledge and Applications
NY Category of CLE Credit:
Skills
Total Credits:
2.0 CLE
Login Instructions:
No Access
You are not logged in. Please Login or register to the event to gain access to the materials and login instructions.
Unlock All The Knowledge and Credit You Need
Leading Provider of Online Continuing Education
It's As Easy as 1, 2, 3
Get Your 1-Year All Access Pass For Only $199
SPEAKERS' FIRMS:
About Mewburn Ellis LLP
MEWBURN ELLIS LLP is one of the UK's largest firms of European Patent Attorneys, European Trade Mark Attorneys and European Design Attorneys, with offices in London, Bristol, Manchester and Cambridge. Our work covers a wide range of technologies, particularly in the fields of Pharmaceutical Chemistry and Biotechnology, and we offer our clients unrivalled expertise and outstanding service.
We work closely with our clients to file and prosecute patent, trade mark and design applications and to handle contentious matters, including oppositions and strive to treat our clients' intellectual property rights not in isolation, but as part of their legal, commercial and industrial environment.
Website: https://www.mewburn.com/
About Carpmaels & Ransford LLP
Carpmaels & Ransford LLP is a leading firm of European patent attorneys. At the vanguard of intellectual property for over 200 years, our pioneering roots in London now extend to Munich and around the globe.
We have been at the forefront of biotechnology right from the start when we started prosecuting cases originating mainly from the West Coast of the US.
Our broad-based technical expertise is organised into dedicated teams with key technical and professional skills specific to both emerging and established industries. Each team represents a pool of specialist knowledge where developments in the law and technology are closely followed. We believe it’s the depth of our expertise, the range of our experience, the huge pride in what we deliver to our clients and our supportive approach to problem solving that marks us out.
For more information, please see www.carpmaels.com.
Website: https://www.carpmaels.com/